Questions for Future Research
Q: Because healthy oligodendrocyte progenitor cells are important for the child’s developing brain, how could further characterization of NG2 isoforms help prevent drugs from damaging those beneficial cells?
Q: Could NG2-binding peptides cross the blood-brain barrier to deliver anti-cancer therapies precisely to tumor sites?
Source: “The Role of NG2 Proteoglycan in Glioma.” S. Yadavilli, E.I. Hwang, R. J. Packer, and J. Nazarian. Published by Translational Oncology on February 2016.
https://innovationdistrict.childrensnational.org/wp-content/uploads/2016/09/R@GNG2DIPG-Image-e1496433328865.jpg 200 300 Diedtra Henderson https://innovationdistrict.childrensnational.org/wp-content/uploads/2017/05/Innovation-District-Logo-tagline.jpg Diedtra Henderson2016-02-21 10:35:162018-05-02 16:57:25The role of NG2 proteoglycan in glioma
You might also like
Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape
Roger Packer, M.D., elected Pediatric Co-Chair by the National Cancer Institute’s Brain Malignancies Steering Committee